๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current controversies surrounding liver transplantation for hepatocellular carcinoma

โœ Scribed by Mauricio F Silva; Alan J Wigg

Book ID
108953756
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
146 KB
Volume
25
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma
โœ Alan P. Venook ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 277 KB ๐Ÿ‘ 1 views

Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma
โœ Taketomi, Akinobu ;Soejima, Yuji ;Yoshizumi, Tomoharu ;Uchiyama, Hideaki ;Yamash ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Springer ๐ŸŒ English โš– 127 KB
Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma
โœ Rick Selby; Zakiyah Kadry; Brian Cari; Andreas Tzakis; Juan R. Madariaga; Shunza ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 597 KB

Total hepatectomy plus liver transplantation was performed on 105 patients considered unsuitable for liver resection. Postoperative 5-year actuarial survivals correlated with the pathologic stage of the tumor: stage I 75%, stage II 68%, stage III 52.1%, and stage IVA 11%. The overall 5-year survival

Liver transplantation and hepatocellular
Liver transplantation and hepatocellular carcinoma
โœ Itsuo Yokoyama; Hiroshi Takagi ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 527 KB

Liver transplantation for advanced hepatocellular carcinoma (HCC) continues to be a subject of debate mostly due to a uniformly high failure rate secondary to recurrence. However, accumulating experiences have enabled detailed analysis of the prognostic factors affecting patient outcome. Clinicopath